21 CFR Part 11 Compliance: Electronic Records in Pharma
Review the core requirements for 21 CFR Part 11 compliance in pharma. This guide explains FDA electronic records, signatures, ALCOA+, and system validation.
Back to Articles
Articles tagged with “alcoa”
GxP Compliance Software: eQMS & Document Management
Analyze leading GxP compliance software, eQMS, and document management platforms for life sciences. Learn how systems meet 21 CFR Part 11 and ALCOA+ rules.
Computer System Validation in Pharma: GAMP 5 Implementation
Understand Computer System Validation (CSV) in pharma. This guide explains GAMP 5 Second Edition implementation, 21 CFR Part 11, and data integrity. Read more.
21 CFR Part 11 Inventory Software: A Compliance Guide
An in-depth review of inventory software meeting 21 CFR Part 11 FDA rules. Explore key requirements like electronic signatures, audit trails, and ALCOA+ princip
GxP Audit Trails for AI: 21 CFR Part 11 & Annex 11 Rules
Explore GxP audit trail requirements for AI systems. Review 21 CFR Part 11, Annex 11, and ALCOA+ rules for logging training data, prompts, and model outputs.
GxP ELN Software: Benchling vs IDBS vs LabArchives Compared
Choosing a GxP ELN? Compare Benchling, IDBS, and LabArchives on features for 21 CFR Part 11 compliance, system validation, and ALCOA data integrity principles.
The Critical Role of Data Quality and Data Culture in Successful AI Solutions for Pharma
A comprehensive analysis of how data quality and data culture are foundational to AI success in pharmaceutical and life sciences organizations, covering assessment frameworks, governance models, regulatory compliance, and practical implementation roadmaps.
Structured Product Labeling (SPL): A Guide to Data Integrity
Updated 2026 guide to Structured Product Labeling (SPL) and data integrity. Covers FDA mandates, EMA ePI roadmap, Health Canada XML-PM, FHIR standards, and ALCOA+ compliance for pharmaceutical labeling.
AI in Good Documentation Practice (GDocP): ALCOA+ & Compliance
Explore how AI impacts Good Documentation Practice (GDocP) and ALCOA+ principles in life sciences. Updated with the 2026 joint FDA-EMA 10 Guiding Principles, EU AI Act implementation timeline, and the EMA's first AI qualification opinion. Learn about efficiency gains, data integrity risks, and regulatory compliance strategies.
ALCOA+ Principles: A Guide to GxP Data Integrity
Learn the 9 ALCOA+ principles for GxP data integrity. Updated for 2026 with ICH E6(R3) finalization, EU GMP Chapter 4 ALCOA++ draft, and latest FDA enforcement trends
Validating Generative AI in GxP: A 21 CFR Part 11 Framework
Updated 2026 framework for validating generative AI in GxP systems. Covers 21 CFR Part 11, EU Annex 22, ISPE GAMP AI Guide, FDA CSA guidance, and FDA-EMA joint AI principles